Related Experiment Video
Updated: Jul 11, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
The epidemiology of acute and chronic hepatitis C
1Epidemiology Section, Hepatitis Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA.
Insights
Millions of Americans have chronic hepatitis C virus (HCV) infection, with injection drug use being a primary transmission route. Healthcare providers need education on HCV risks, patient history, and prevention strategies.
Area of Science:
- Hepatology
- Infectious Diseases
- Public Health
Background:
- An estimated 3.9 million Americans live with chronic hepatitis C virus (HCV) infection.
- Young adults represent a significant portion of those with chronic HCV, facing long-term health risks.
Purpose of the Study:
- To highlight the evolving transmission dynamics of HCV.
- To emphasize the critical need for healthcare professional education on HCV risks, patient evaluation, and prevention.
Main Methods:
- Review of historical and recent HCV transmission data.
- Analysis of changing exposure patterns, including blood transfusions, injection drug use, and sexual transmission.
Main Results:
- Injection drug use remains a significant factor in HCV transmission.
- Blood transfusions, once a major source, now account for fewer new infections.
- Sexual transmission may contribute 10-20% of HCV cases, often under-ascertained.
Conclusions:
- Healthcare providers require comprehensive education on HCV management and prevention.
- Thorough risk behavior histories and appropriate screening of high-risk individuals are essential.
- Addressing HCV requires understanding its changing epidemiology and transmission routes.
Abstract:
Although the incidence of newly acquired acute hepatitis C virus (HCV) infection has declined, an estimated 3.9 million Americans are chronically infected with HCV, most of whom are young adults who will be at risk of the severe consequences of their infection in the next 10 to 20 years. The relative importance of the two most common exposures associated with the transmission of HCV has changed over time. Blood transfusions, which account for a substantial proportion of HCV infections acquired more than 10 years ago, account for only a small portion of recently acquired infections. In contrast, injection drug use has accounted for a substantial portion of HCV infections during both the remote and recent past. Sexual exposures, which have been poorly ascertained particularly among patients with chronic hepatitis C, may account for 10% to 20% of HCV transmissions. Physicians and other health care professionals need to be educated not only about the appropriate medical management of HCV infected patients, but also about the known and potential risks for HCV infection, the need to ascertain complete risk behavior histories from their patients, the appropriate evaluation of high-risk patients for evidence of infections, and the recommendations for prevention.
Related Concept Videos
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Hepatitis
Viral Hepatitis I: Introduction
Cirrhosis I: Introduction
Cirrhosis II: Pathophysiology

